Market revenue in 2023 | USD 204.9 million |
Market revenue in 2030 | USD 336.5 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.49% in 2023. Horizon Databook has segmented the Italy cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
A strong presence of well-established & emerging cell separation product manufacturers and the continuous organic & inorganic growth strategies being adopted by them are expected to create a lucrative environment for market growth.
For instance, in April 2019, Kinetic River, a U.S.-based company signed an agreement with Italy-based EMC2 to distribute its flow cytometry products and services in Italy. Furthermore, in the recent past, the Italian biotech industry exhibited notable growth due to tremendous academic and industrial research.
Milan is the hub of the biotech sector in Italy, housing approximately 35% of all biotech companies. Furthermore, in February 2020, an Italy-based company, AurorA-TT, in collaboration with drug discovery companies Italfarmaco and Rottapharm Biotech, launched the biotech investment enterprise, AurorA.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy cell separation market , including forecasts for subscribers. This country databook contains high-level insights into Italy cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account